Skip to main content

International Cancer Conference Journal OnlineFirst articles

21-05-2024 | Checkpoint Inhibitors | Case Report - Immunotherapy

Complete response induced by nivolumab monotherapy in gastric neuroendocrine carcinoma: a case report

No standard treatment has been established for gastric neuroendocrine carcinoma (G-NEC). We present the case of a patient with recurrent G-NEC who achieved a complete response (CR) with nivolumab. A woman in her 70 s, with no significant medical …

Authors:
Misa Onishi, Mitsuhiro Furuta, Emi Yoshioka, Takanobu Yamada, Takanori Hama, Kyoko Furusawa, Kei Hayashi, Yasuhiro Inokuchi, Nozomu Machida, Junji Furuse, Shin Maeda

11-05-2024 | Breast Cancer | Case Report - Genetics

Dynamic change of cancer genome profiling in metachronous bilateral breast cancer with BRCA pathogenic variant

A 61-year-old woman with BRCA2 pathogenic variant had been treated for 20 years and showed dynamic changes in the genomic profile of her metachronous bilateral breast cancer and metastases. She underwent right breast conservation surgery at age …

Authors:
Ayako Kimura, Hiroshi Nakagomi, Masayuki Inoue, Tomomi Oka, Yosuke Hirotsu, Kenji Amemiya, Hitoshi Mochizuki, Toshio Oyama, Masao Omata

07-05-2024 | Hepatocellular Carcinoma | Case Report - Surgery

A patient who underwent conversion surgery after atezolizumab plus bevacizumab for hepatocellular carcinoma with portal vein thrombosis and perihepatic lymph node metastases achieved a pathological complete response

Here, we present a patient with hepatocellular carcinoma complicated by tumor thrombosis into the main portal trunk and perihepatic lymph node metastases who was treated with atezolizumab plus bevacizumab. Shrinkage of the main tumor, portal vein …

Authors:
Masayuki Okuno, Hideko Ohama, Ikuo Nakamura, Makoto Yoshida, Daisuke Shirai, Takahito Hirai, Hiroaki Fuji, Ami Kurimoto, Tomohiro Okamoto, Hideaki Sueoka, Kenjiro Iida, Masaharu Tada, Takako Kihara, Hironori Tanaka, Seiko Hirono

07-05-2024 | Chondrosarcoma | Case Report - Pathology

Unusual soft tissue metastases in a patient with chondrosarcoma: a case report

Chondrosarcoma (CS) is the second most frequent primary malignant bone tumour, characterized by production of non‐osteoid cartilage matrix. Up to more than 30% of patients with CS present distant metastases, and the lungs represent the preferred …

Authors:
Giuseppe Francesco Papalia, Sisith Ariyaratne, Sumathi Vaiyapuri, Rajesh Botchu, Vineet Kurisunkal

30-04-2024 | Liposarcoma | Case Report - Pathology

A case of dedifferentiated liposarcoma discovered due to an intrascrotal calcified ossification

Dedifferentiated liposarcoma is a rare cancer with a poor prognosis. A 52-year-old man presented with a chief complaint of a mass in his left scrotum. He came with suspected testicular tumor, but all the measured tumor markers were negative.

Authors:
Haruna Arai, Hirofumi Sogabe, Shinnosuke Morikawa, Osuke Arai, Ryuta Watanabe, Akira Ozawa, Akira I. Hida, Tokuhiro Iseda, Kenichi Kohashi, Yoshinao Oda

26-04-2024 | Priapism | Case Report - Complication

Priapism as an initial manifestation in an adult patient with chronic myeloid leukemia in Japan: case report and review of the literature

We report the first documented Japanese case in the English literature of chronic myeloid leukemia (CML) in which priapism was the presenting symptom. Priapism, a rare manifestation in CML patients, is particularly uncommon in Japan. This can be …

Authors:
Yuya Masuda, Hisaharu Shikata, Hiroshi Sawachika, Masahiko Kaneko

22-04-2024 | Vasculitis | Case Report - Complication

An underrecognized association: immune checkpoint inhibitor-related aortitis, a case report with the review of the literature

Immune-checkpoint inhibitors (ICIs) are considered as the novel treatment modality in certain cancers. They may soon be used widely even as the first-line option for cancer treatment due to their remarkable efficacies and impacts on survival …

Authors:
Reşit Yıldırım, Aida Shikhaliyeva, Hüseyin İçer, Hakan Deveci, Emre Entok, Döndü Üsküdar Cansu, Cengiz Korkmaz

22-04-2024 | Urothelial Cancer | Case Report - Pathology

Renal pelvic plasmacytoid subtype urothelial carcinoma accompanied with solitary mammary metastasis

A 72-year-old female was referred to our institution for further evaluation of right renal tumor detected during work-up for macroscopic hematuria in other hospital. CT urography performed at our institution suggested renal pelvic tumor. Voiding …

Authors:
Keisuke Matsubara, Nozomi Hayakawa, Koichiro Aida, Junki Koike, Eiji Kikuchi

22-04-2024 | Cytostatic Therapy | Case Report - Surgery

Successful curative treatment for a ruptured pancreatic acinar cell carcinoma by radical resection following modified FOLFIRINOX: a case report and literature review

Pancreatic acinar cell carcinoma (PACC) is a rare pancreatic tumor type, and ruptured pancreatic tumors are rarer. Computed tomography (CT) in a 48-year-old man incidentally revealed a raptured pancreatic tail tumor. The patient was treated …

Authors:
Kei Yamane, Kosuke Tsukano, Yosuke Umino, Tadashi Nagami, Koji Tarumoto, Kuniaki Hattori, Ryo Maemoto, Junji Iwasaki, Akiyoshi Kanazawa

Open Access 18-04-2024 | Prostate Cancer | Case Report - Pathology

Aggressive variant prostate cancer with multiple subcutaneous metastases: a case report

A 71-year-old man with bone metastasis of hormone-sensitive prostate cancer was treated with androgen deprivation therapy and apalutamide. Radium-223 and radiation therapy were administered after it become castration resistant. Although …

Authors:
Yusuke Hoshino, Kent Kanao, Yu Miyama, Takeo Kosaka, Go Kaneko, Suguru Shirotake, Masanori Yasuda, Masafumi Oyama

Open Access 18-04-2024 | Colorectal Cancer | Case Report - Molecularly Targeted Therapy

BRAF-mutant microsatellite-stable rectal cancer with acquired KRAS mutation leading to drug resistance in liver metastasis

BRAF-mutant microsatellite-stable colorectal cancer (CRC), metastasized to distant sites, is associated with a poor prognosis. However, the BEACON CRC regimen, comprising a BRAF inhibitor, MEK inhibitor, and anti-EGFR antibody, offered a prolonged …

Authors:
Kunitoshi Shigeyasu, Hideki Yamamoto, Toshiaki Takahashi, Kazuya Moriwake, Masashi Kayano, Sho Takeda, Yuki Matsumi, Yuzo Umeda, Yoshitaka Kondo, Fuminori Teraishi, Kazuya Yasui, Tomokazu Fuji, Shunsuke Kagawa, Toshiyoshi Fujiwara

16-04-2024 | Hyperparathyroidism | Case Report - Genetics

Multiple endocrine neoplasia type 1 with MEN1 variant of unknown significance, in a patient after the diagnosed of pancreatic neuroendocrine neoplasia

Duodenopancreatic neuroendocrine neoplasia (DP-NEN) is in approximately 10% of cases of multiple endocrine neoplasia type 1 (MEN1). We encountered a case in which the onset of NEN led to suspicion and diagnosis of MEN1. Although genetic testing …

Authors:
Yuko Tanaka, Takafumi Niitani, Takatsugu Matsumoto, Akihito Abe, Kazuyuki Ishida, Taku Aoki

13-04-2024 | Breast Cancer | Case Report - Complication

Significant improvement in paraneoplastic neurological syndromes without identifiable anti-neural antibodies in patients with breast cancer after breast surgery

Paraneoplastic neurological syndromes (PNS) are neurological disorders that occur in close association with tumors without direct metastasis or invasion of the tumors and in which anti-neural antibodies may be present. Cerebellar ataxia is a …

Authors:
Tomohiro Oshino, Karin Shikishima, Yumi Moriya, Kaede Ishikawa, Megumi Abe, Hiroaki Yaguchi, Mitsuchika Hosoda, Keiko Tanaka, Ichiro Yabe, Masato Takahashi

10-04-2024 | Glioma | Case Report - Molecularly targeted therapy

Successful treatment of pediatric patients with high-grade gliomas featuring leptomeningeal metastases by targeting BRAF V600E mutations with dabrafenib plus trametinib: two illustrative cases

A combination of BRAF and MEK inhibitors is reported to be effective for gliomas with the BRAF V600E mutation; however, its efficacy in gliomas with leptomeningeal metastases (LMM) is still unknown. In this report, we describe two pediatric …

Authors:
Yuki Kawaguchi, Yuko Watanabe, Yasuji Miyakita, Makoto Ohno, Chitose Ogawa, Masamichi Takahashi, Shunsuke Yanagisawa, Takayuki Mukai, Hiroshi Igaki, Hirokazu Sugino, Akihiko Yoshida, Yoshitaka Narita

02-04-2024 | Kaposi Sarcoma | Case Report - Pathology

Disseminated AIDS-associated Kaposi sarcoma without cutaneous involvement: a case report and review of literature

Disseminated AIDS-associated Kaposi sarcoma (KS) without cutaneous lesions is rare and can present in varying ways. Diagnosis is even more challenging now when incidence of KS is on the decline. A high index of suspicion is required for early …

Authors:
Vera Mbamulu, Grace A. Otokpa, Bob A. Ukonu, Perpetua U. Ibekwe

01-04-2024 | Sarcoma | Case report - Diagnosis

A challenging case of an adamantinoma of fibula with soft tissue mass harboring distinct histopathology

We present a case of adamantinoma that originated from the fibula and had a large soft tissue component measuring approximately 6 cm. Clinical, radiological, and pathological investigations initially suggested that the tumor might be a …

Authors:
Recep Öztürk, Umut Baran Zengin, Fisun Ardic Yukruk, Kemal Yücel, Furkan Öztürk, Kemal Kösemehmetoğlu

01-04-2024 | Lenvatinib | Case Report - Molecularly targeted therapy

Long-term response to MEK inhibitor monotherapy in a patient with papillary thyroid carcinoma harboring BRAF V600E mutation

Solid tumors harboring mutations in the Braf gene (BRAF) are currently treated by combination Braf/MEK inhibitor therapy, and there is an extensive literature on patient response rates. Alternatively, few studies have documented the clinical …

Authors:
Yuko Takano, Tomoya Shimokata, Hiroshi Urakawa, Toyone Kikumori, Yuichi Ando

30-03-2024 | Myocarditis | Case report - Complication

An autopsy case of lung adenocarcinoma with immune checkpoint inhibitor-induced pneumonia and fulminant myocarditis following pembrolizumab administration: a case report

Immune checkpoint inhibitors (ICIs) are the current standard of care for non-small-cell lung cancer (NSCLC). Myocarditis is a rare but serious immune-related adverse event (irAE) associated with ICI therapy. We present a patient who received a …

Authors:
Takahiko Hashimoto, Kosuke Takahashi, Kosuke Ito, Kahori Iwade, Atsushi Torii, Minoru Sugihara, Haruka Kondo, Toru Hara

Open Access 29-03-2024 | Erythema Exsudativum Multiforme | Case Report - Complication

PD-L1 expression in keratinocyte and infiltration of CD4 + T lymphocyte can predict a severe type of erythema multiforme major induced by the anti-PD-1 antibody, pembrolizumab

Skin toxicity is the most common adverse event of treatment with immune check point inhibitors. Among them, erythema multiforme is a rare occurrence with a frequency of 4%, with most of the cases developing grade 1/2 disease. We experienced high …

Authors:
Ryohei Kadoi, Taichi Yoshida, Mai Noto, Aya Toyoshima, Sino Fujii, Koji Fukuda, Kazuhiro Shimazu, Daiki Taguchi, Hanae Shinozaki, Naoki Kodama, Michihiro Kono, Hiroshi Nanjyo, Hiroyuki Shibata

27-03-2024 | Stem Cell Transplantation | Case report - Complication

Cardiac-output response to exercise after allogeneic hematopoietic stem cell transplantation: a case report with a 2-year follow-up

Cardiac-output response to exercise was evaluated over a 2-year period in hematopoietic stem cell transplant recipients treated with cardiotoxic drugs. During the study period, resting cardiac function was normal; however, the cardiac output …

Authors:
Shinya Yoshida, Goro Sakurai, Tetsutaro Yahata